REVVITY, INC Payments for Hedge, Financing Activities
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- REVVITY, INC payments for hedge, financing activities for the quarter ending 2019-12-29 was -$300.00K, a 107.86% decline year-over-year.
- REVVITY, INC payments for hedge, financing activities for the quarter ending 2019-09-29 was -$100.00K.
- REVVITY, INC payments for hedge, financing activities for the quarter ending 2019-06-30 was $25.00K.
- REVVITY, INC payments for hedge, financing activities for the quarter ending 2019-03-31 was $1.68M, a 95.37% decline year-over-year.
- REVVITY, INC payments for hedge, financing activities for fiscal 2021 was $4.60M, a 253.85% increase from fiscal 2019.
- REVVITY, INC payments for hedge, financing activities for fiscal 2019 was $1.30M, a 96.19% decline from fiscal 2018.
- REVVITY, INC payments for hedge, financing activities for fiscal 2018 was $34.10M.
| Period end | Payments for Hedge, Financing Activities 3 month | Payments for Hedge, Financing Activities 12 month |
|---|---|---|
| 2021-01-03 | $4.60M 10-K · filed 2021-03-02 | |
| 2019-12-29 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.30M 10-K · filed 2021-03-02 |
| 2019-09-29 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.42M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.09M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | $1.68M 10-Q · filed 2019-05-07 | -$394.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-30 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $34.10M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2018-07-01 | -$3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | |
| 2018-04-01 | $36.17M 10-Q · filed 2018-05-08 | |
| 2017-10-01 | $7.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | |
| 2017-07-02 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | |
| 2017-04-02 | $1.57M 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |